Rangers Roundup: Nils Lundkvist eliminated in SHL playoffs; ELC next, Karl Henriksson to stay in Sweden next season, and more

By Anthony Scultore
Nils Lundkvist (Lulea/SHL)

Nils Lundkvist’s SHL team Lulea was eliminated in game 7 yesterday. The future blue-line star is committed to Team Sweden for the upcoming IIHF World Championships but could be signing his ELC soon. If you recall, after the trade deadline Jeff Gorton was asked about Nils and he stated that he would be coming over next season.

Nils Lundkvist completes stellar season

Lulea was eliminated in seven games with Nils Lundkvist completing his season with two playoff goals. In 166 career SHL games he had 78 points which is the most points by any defenseman under 21 in league history.

  • Ranked fifth in the SHL (ranked second among SHL defensemen) in shots on goal in 2020-21 (156); was one shot on goal shy of tying the leader among SHL defensemen for the season
  • Tallied 14 goals and 32 points this season, establishing an SHL career-high in each category; led SHL defensemen in goals and power play goals (eight) this season
    • His 14 goals are the most by a defenseman in one season as a U21 player or younger in SHL history
  • Ranked 12th in the SHL in average ice time in 2020-21 (21:24)

Notes courtesy New York Rangers

Karl Henriksson says he will stay in Sweden next season

new york rangers prospect report
Karl Henriksson (Journal News)

The Rangers signed 2019 second round pick Karl Henriksson to his ELC starting next season. The 20 year-old pivot has played 44 games for Frolunda and has 7 points. He is also one of just 13 U20 players in the entire league. A boy amongst men if you will.

After signing his deal he told Swedish media that it was “super cool” and “a dream come true.” Then he revealed that it was already decided that he will play next season in the SHL again with Frolunda. “Yes exactly,” he responded about playing in Sweden next season. “And I think that feels good.”

NHL Scores: Golden Knights clinch

All the NHL games from yesterday. Read more.